We are live on
!
Find out more
BM
Bridger Management Portfolio holdings
AUM
$128M
1-Year Est. Return
9.54%
This Fund
S&P 500
This Quarter
Est. Return
+6.66%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$1.5B
AUM Growth
+$67.2M
(+4.7%)
Cap. Flow
-$753K
Cap. Flow
% of AUM
-0.05%
Top 10 Holdings %
Top 10 Hldgs %
40.55%
Holding
50
New
10
Increased
5
Reduced
8
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$52.9M |
| 2 |
Eli Lilly
LLY
|
+$44.9M |
| 3 |
Vodafone
VOD
|
+$43.9M |
| 4 |
Tenet Healthcare
THC
|
+$34.6M |
| 5 |
Labcorp
LH
|
+$32.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$39.9M |
| 2 |
Gilead Sciences
GILD
|
+$37.9M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$37.7M |
| 4 |
PRMW
Primo Water Corporation
PRMW
|
+$36.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$30.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 40.7% |
| 2 | Consumer Discretionary | 21.95% |
| 3 | Financials | 11.48% |
| 4 | Communication Services | 9.88% |
| 5 | Technology | 4.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Zoetis
ZTS
$32.3B
| $32.8M | 2.19% |
1,134,538
| – | – |
|
27
PennyMac Financial
PFSI
$3.9B
| $32M | 2.14% |
1,925,000
+200,000
| +12% | +$3.48M |
|
28
Alnylam Pharmaceuticals
ALNY
$27.1B
| $29.5M | 1.97% |
440,000
| – | – |
|
29
Accuray
ARAY
$31.5M
| $28.8M | 1.92% |
3,000,000
+775,000
| +35% | +$7.33M |
|
30
Polaris
PII
$3.77B
| $26.5M | 1.77% |
190,000
| – | – |
|
31
Bruker
BRKR
$9.59B
| $18.6M | 1.24% |
815,000
| – | – |
|
32
TG Therapeutics
TGTX
$8B
| $17.6M | 1.17% |
2,547,000
+900,000
| +55% | +$5.33M |
|
|
SC
33
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $17.2M | 1.15% |
+715,000
| New | +$17.7M |
|
34
Regeneron Pharmaceuticals
REGN
$77.6B
| $16.5M | 1.1% |
+55,000
| New | +$16.9M |
|
35
Cardiff Oncology
CRDF
$65.9M
| $12.3M | 0.82% |
29,762
| – | – |
|
36
Churchill Downs
CHDN
$5.91B
| $9.13M | 0.61% |
+600,000
| New | +$9.18M |
|
|
IDIX
37
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
| $9.04M | 0.6% |
1,500,000
-750,000
| -33% | -$5.23M |
|
38
Liberty Global Class A
LBTYA
$3.58B
| $8.74M | 0.58% |
+254,618
| New | +$8.95M |
|
39
Liberty Global Class C
LBTYK
$3.49B
| $8.55M | 0.57% |
+259,580
| New | +$8.67M |
|
|
RGDX
40
DELISTED
RESPONSE GENETICS, INC COMMON SHS (DELAWARE)
RGDX
| $7.14M | 0.48% |
6,000,000
| – | – |
|
41
Casella Waste Systems
CWST
$5.65B
| $6.11M | 0.41% |
1,196,150
-597,357
| -33% | -$3.19M |
|
|
SODA
42
DELISTED
SodaStream International Ltd
SODA
| $5.07M | 0.34% |
115,000
| – | – |
|
43
Verastem
VSTM
$490M
| $2.16M | 0.14% |
16,667
| – | – |
|
44
Centene
CNC
$30.6B
| – | – |
-1,200,000
| Closed | -$17.7M |
|
|
45
Gilead Sciences
GILD
$162B
| – | – |
-505,000
| Closed | -$37.9M |
|
|
PRMW
46
DELISTED
Primo Water Corporation
PRMW
| – | – |
-4,550,000
| Closed | -$36.7M |
|
|
MDCO
47
DELISTED
Medicines Co
MDCO
| – | – |
-630,000
| Closed | -$24.3M |
|
|
FRX
48
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
-665,000
| Closed | -$39.9M |
|
|
TWC
49
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| – | – |
-140,000
| Closed | -$19M |
|
Similar funds
SHFC
IUC
PC
SIM
PIA
S
CF
BC
Bridger Management's Q1 2014 Portfolio in Review
As of Q1 2014, Bridger Management held 50 positions worth $1.5B, up 4.7% from $1.43B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Bridger Management's Q1 2014 filing shows 10 new, 5 increased, 8 reduced and 7 closed positions. Its largest new stake was Merck: 1,021,800 shares worth $55.4M. The largest sale was FOREST LABORATORIES INC, an estimated $39.9M.
By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Financials.
- Bridger Management's largest Q1 2014 buy was Merck: 1,021,800 shares worth $55.4M.
- Bridger Management added most to Accuray in Q1 2014, an estimated $7.33M increase.
- Bridger Management's biggest Q1 2014 reduction was MALLINCKRODT PUBLIC LIMITED COMPANY, cutting an estimated $37.7M.
- Bridger Management fully exited FOREST LABORATORIES INC in Q1 2014, selling an estimated $39.9M.
- Bridger Management's ten largest holdings make up 41% of its $1.5B portfolio in Q1 2014.
- Bridger Management opened 10 new positions and closed 7 in Q1 2014.
- Bridger Management's portfolio value rose 4.7% quarter-over-quarter to $1.5B.
Based on Bridger Management's 13F filing for Q1 2014, filed 15 May 2014.